CLINICAL TRIALS PROFILE FOR ANAGRELIDE HYDROCHLORIDE
✉ Email this page to a colleague
All Clinical Trials for anagrelide hydrochloride
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00175838 ↗ | Primary Thrombocythaemia 1 Trial | Completed | Cambridge University Hospitals NHS Foundation Trust | N/A | 1997-07-01 | The purpose of this trial is to see if Hydroxyurea + aspirin is a better treatment than aspirin alone for Intermediate Risk Primary Thrombocythemia (PT) patients. |
NCT00175838 ↗ | Primary Thrombocythaemia 1 Trial | Completed | Institute of Cancer Research, United Kingdom | N/A | 1997-07-01 | The purpose of this trial is to see if Hydroxyurea + aspirin is a better treatment than aspirin alone for Intermediate Risk Primary Thrombocythemia (PT) patients. |
NCT00175838 ↗ | Primary Thrombocythaemia 1 Trial | Completed | University of Cambridge | N/A | 1997-07-01 | The purpose of this trial is to see if Hydroxyurea + aspirin is a better treatment than aspirin alone for Intermediate Risk Primary Thrombocythemia (PT) patients. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for anagrelide hydrochloride
Condition Name
Clinical Trial Locations for anagrelide hydrochloride
Trials by Country
Clinical Trial Progress for anagrelide hydrochloride
Clinical Trial Phase
Clinical Trial Sponsors for anagrelide hydrochloride
Sponsor Name